Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
11.0 |
Antitumor endpoint evaluated on day 14; 04/05 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
20.0 |
Antitumor endpoint evaluated on day 14; 06/06 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
-43.0 |
Antitumor endpoint evaluated on day 14; 06/06 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
8.0 |
Antitumor endpoint evaluated on day 14; 06/06 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-64.0 |
Antitumor endpoint evaluated on day 14; 04/06 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-30.0 |
Antitumor endpoint evaluated on day 14; 06/06 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 14; 00/06 animals surviving on day 14 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 14; 00/06 animals surviving on day 14 |